| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_41686a979f961bce6a9855b4b409a5b8 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-127 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-704
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-127
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1652 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-704
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-127 |
| filingDate |
2019-06-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c711ea0ce30ca396f7a2f57b6eda5471
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5db69972fca02cfe7a90c361c1d15f54
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e8f1d0efa923c995e1df91b57fdadafb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_471ec4bddcc035f0ab803b79f55e417e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d69776dab3ac7bbde6c7ed9bcfc7c772
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_87deabda55590b9190df5a78cc0892f9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ae91ded8b322fa6efdb488313f4ed5da
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4f828f55df39eef5463694ebdaed9507
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_79f7c932aa5e64a558e9aaac9e37811b |
| publicationDate |
2022-04-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-3986379-A1 |
| titleOfInvention |
Biodegradable drug-eluting embolic particles for delivery of therapeutic agents |
| abstract |
Drug-loaded microbead compositions including a plurality of individual microbeads of a biodegradable material, a plurality of individual vesicular agents, a first therapeutic agent, and a second therapeutic agent different from the first therapeutic agent. The vesicular agents include at least one lipid bilayer surrounding a vesicular core. The first therapeutic agent is associated with the individual vesicular agents. For example, the first therapeutic agent may be contained within the individual vesicular agents or may be associated with the individual vesicular agents by ionic or non-covalent interaction. The second therapeutic agent is different from the first therapeutic agent and contained within the individual microbeads or associated with the individual microbeads through ionic or non-covalent interaction. The second therapeutic agent may or may not be associated with the individual vesicular agents. Drug-loaded biodegradable microbead compositions include microbeads of biodegradable material and a therapeutic agent associated with the microbeads. |
| priorityDate |
2019-06-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |